Cognition across the lifespan: Antiepileptic drugs, epilepsy, or both?

Epilepsy and Behavior

Volumn 17, Issue 1, 2010, Pages 1-5

  Hermann, Bruce ^a   Meador, Kimford J ^b   Gaillard, William D ^c   Cramer, Joyce A ^d  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b EMORY UNIVERSITY   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d YALE UNIVERSITY   (United States)

Author keywords

Antiepileptic drugs; Attention; Cognition; Epilepsy; Executive function; Memory

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; CORTICOTROPIN; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREDNISONE; PRIMIDONE; RUFINAMIDE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

AGING; ATTENTION; ATTENTION DEFICIT DISORDER; BRAIN SIZE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COMORBIDITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; EPILEPSY; FUNCTIONAL STATUS; HUMAN; INFANTILE SPASM; INTELLIGENCE; LANGUAGE PROCESSING; LENNOX GASTAUT SYNDROME; LIFESPAN; MEDICAL DECISION MAKING; NEUROPATHOLOGY; NEUROTOXICITY; ONSET AGE; PSYCHOMOTOR PERFORMANCE; REVIEW; SEIZURE; TEMPORAL LOBE EPILEPSY; VERBAL MEMORY; VISUAL MEMORY;

AGE FACTORS; ANTICONVULSANTS; ATTENTION; COGNITION DISORDERS; EPILEPSY; EXECUTIVE FUNCTION; HUMANS; INTELLIGENCE; LANGUAGE; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; VERBAL LEARNING;

EID: 72949114263     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2009.10.019     Document Type: Review

References (53)

1. Bernasconi N., Bernasconi A., Caramanos Z., Antel S.B., Andermann F., and Arnold D.L. Mesial temporal damage in temporal lobe epilepsy: a volumetric MRI study of the hippocampus, amygdala and parahippocampal region. Brain 126 Pt. 2 (2003) 462-469
2. Bernasconi N., Bernasconi A., Andermann F., Dubeau F., Feindel W., and Reutens D.C. Entorhinal cortex in temporal lobe epilepsy: a quantitative MRI study. Neurology 52 (1999) 1870-1876
3. Kuzniecky R., Bilir E., Gilliam F., Faught E., Martin R., and Hugg J. Quantitative MRI in temporal lobe epilepsy: evidence for fornix atrophy. Neurology 53 (1999) 496-501
4. Natsume J., Bernasconi N., Andermann F., and Bernasconi A. MRI volumetry of the thalamus in temporal, extratemporal, and idiopathic generalized epilepsy. Neurology 60 (2003) 1296-1300
5. Oyegbile T.O., Dow C., Jones J., et al. The nature and course of neuropsychological morbidity in chronic temporal lobe epilepsy. Neurology 62 (2004) 1736-1742
6. Lin J.J., Salamon N., Lee A.D., et al. Reduced neocortical thickness and complexity mapped in mesial temporal lobe epilepsy with hippocampal sclerosis. Cereb Cortex 17 (2007) 2007-2018
7. Hermann B.P., Seidenberg M., Dow C., et al. Cognitive prognosis in chronic temporal lobe epilepsy. Ann Neurol 60 (2006) 80-87
8. Bourgeois B.F., Prensky A.L., Palkes H.S., et al. Intelligence in epilepsy: a prospective study in children. Ann Neurol 14 (1983) 438-444
9. Williams J., Griebel M.L., and Dykman R.A. Neuropsychological patterns in pediatric epilepsy. Seizure 7 (1998) 223-228
10. Kolk A., Beilmann A., Tromberg T., Napa A., and Talvik T. Neurocognitive development of children with congenital unilateral brain lesion and epilepsy. Brain Dev 23 (2001) 88-96
11. Oostrom K.J., Schouten A., Kruitwagen C.L., et al. Behavioral problems in children with newly diagnosed idiopathic or cryptogenic epilepsy attending normal schools are in majority not persistent. Epilepsia 44 (2003) 97-106
12. Hermann B., Jones J., Sheth R., Dow C., Koehn M., and Seidenberg M. Children with new-onset epilepsy: neuropsychological status and brain structure. Brain 129 Pt. 10 (2006) 2609-2619
13. Berg A.T., Langfitt J.T., Testa F.M., et al. Global cognitive function in children with epilepsy: a community-based study. Epilepsia 49 (2008) 608-614
14. Schoenfeld J., Seidenberg M., Woodard A., et al. Neuropsychological and behavioral status of children with complex partial seizures. Dev Med Child Neurol 41 (1999) 724-731
15. Caplan R., Siddarth P., Stahl L., et al. Childhood absence epilepsy: behavioral, cognitive, and linguistic comorbidities. Epilepsia 49 (2008) 1838-1846
16. Oostrom K.J., Smeets-Schouten A., Kruitwagen C.L., et al. Not only a matter of epilepsy: early problems of cognition and behavior in children with "epilepsy only"-a prospective, longitudinal, controlled study starting at diagnosis. Pediatrics 112 6, Pt. 1 (2003) 1338-1344
17. Berg A.T., Smith S.N., Frobish D., et al. Special education needs of children with newly diagnosed epilepsy. Dev Med Child Neurol 47 (2005) 749-753
18. McNelis A.M., Dunn D.W., Johnson C.S., et al. Academic performance in children with new-onset seizures and asthma: a prospective study. Epilepsy Behav 10 (2007) 311-318
19. Jones J.E., Hermann B.P., Barry J.J., Gilliam F., Kanner A.M., and Meador K.J. Clinical assessment of Axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation. J Neuropsychiatry Clin Neurosci 17 (2005) 172-179
20. Austin J.K., Hareziak J., and Dunn D.W. Behavior problems in children before first recognized seizure. Pediatrics 107 (2001) 115-122
21. Hesdorffer D.C., Ludvigsson P., Olafsson E., et al. ADHD as a risk factor for incident unprovoked seizures and epilepsy in children. Arch Gen Psychiatry 61 (2004) 731-736
22. Meador K.J., Loring D.W., Allen M.E., et al. Comparative effects of carbamazepine and phenytoin in healthy adults. Neurology 41 (1991) 1537-1540
23. Meador K.J., Loring D.W., Abney O.L., et al. Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia 34 (1993) 153-157
24. Meador K.J., Loring D.W., Moore E.E., et al. Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults. Neurology 45 (1995) 1494-1499
25. Meador K.J., Loring D.W., Ray P.G., et al. Differential cognitive effects of carbamazepine and gabapentin. Epilepsia 40 (1999) 1279-1285
26. Meador K.J., Loring D.W., Ray P.G., et al. Differential cognitive effects of carbamazepine and lamotrigine. Neurology 56 (2001) 1177-1182
27. Meador K.J., Loring D.W., Vahle V.J., et al. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers. Neurology 64 (2005) 2108-2114
28. Meador K.J., Gevins A., Loring D.W., et al. Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam. Neurology 69 (2007) 2077-2084
29. Salinsky M.C., Spencer D.C., Oken B.S., et al. Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers. Epilepsy Behav 5 (2004) 894-902
30. Salinsky M.C., Storzbach D., Spencer D.C., et al. Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology 64 (2005) 792-798
31. Gilliam F.G., Fessler A.J., Baker G., et al. Systematic screening allows reduction of adverse antiepileptic drug effects. Neurology 62 (2004) 23-27
32. Craig I., and Tallis R. Impact of valproate and phenytoin on cognitive function in elderly patients: results of a single-blind randomized comparative study. Epilepsia 35 (1994) 381-390
33. Ramsay R.E., Rowan A.J., and Pryor F.M. Special considerations in treating the elderly patient with epilepsy. Neurology 62 5, Suppl. 2 (2004) S24-S29
34. Rowan A.J., Ramsey R.E., Collins J.F., et al. New-onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 64 (2005) 1868-1873
35. Loring D.W., and Meador K.J. Cognitive side effects of antiepileptic drugs in children. Neurology 62 (2004) 872-877
36. Meador K.J., Baker G.A., Browning N., et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 360 (2009) 1597-1605
37. Vining E.P., Mellitis E.D., Dorsen M.M., et al. Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid. Pediatrics 80 (1987) 165-174
38. Farwell J.R., Lee Y.J., Hirtz D.G., et al. Phenobarbital for febrile seizures: effects on intelligence and on seizure recurrence. N Engl J Med 322 (1990) 364-369
39. Pressler R.M., Binnie C.D., Coleshill S.G., Chorley G.A., and Robinson R.O. Effect of lamotrigine on cognition in children with epilepsy. Neurology 66 (2006) 1495-1499
40. Pulsifer M.S., Brandt J., Salorio C.F., et al. The cognitive outcome of hemispherectomy in 71 children. Epilepsia 45 (2004) 243-254
41. Lux A.L., Edwards S.W., Hancock E., et al. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet 364 (2004) 1773-1778
42. Lux A.L., Edwards S.W., Hancock E., et al., United Kingdom Infantile Spasms Study. The United Kingdom Infantile Spasms Study comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol 4 (2005) 712-717
43. The Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993;328:29-33.
44. Sachdeo R.C., Glauser T.A., Ritter F., et al. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome Topiramate YL Study Group. Neurology 52 (1999) 1882-1887
45. Motte J., Trevathan E., Arvidsson J.F., et al. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. N Engl J Med 337 (1997) 1807-1812 [Erratum in: N Engl J Med 1998;339:851-2]
46. Glauser T., Kluger G., Sachdeo R., et al. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology 70 (2008) 1950-1958
47. Gaillard W.D., Weinstein S., Conry J.A., et al. Prognosis of children with partial epilepsy: MRI and serial FDG-PET. Neurology 68 (2007) 655-659
48. Harvey A.S., Berkovic S.F., Wrennall J.A., et al. Temporal lobe epilepsy in childhood: clinical, EEG, and neuroimaging findings and syndrome classification in a cohort with new-onset seizures. Neurology 49 (1997) 960-968
49. Spooner C.G., Berkovic S.F., Mitchell L.A., et al. New-onset temporal lobe epilepsy in children: lesion on MRI predicts poor seizure outcome. Neurology 67 (2006) 2147-2153
50. Weibe S., Blume W.T., Girvin J.P., et al. Effectiveness and efficiency of surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 345 (2001) 311-318
51. Theodore W.H., Bhatia S., Hatta J., et al. Hippocampal atrophy, epilepsy duration, and febrile seizures in patients with partial seizures. Neurology 52 (1999) 132-136
52. Theodore W.H., Kelley K., Toczek M., and Gaillard W.D. Epilepsy duration, febrile seizures, and cerebral glucose metabolism. Epilepsia 45 (2004) 276-279
53. Spanaki M.V., Kopylev L., Liow K., et al. Relationship of seizure frequency to hippocampus volume in temporal lobe epilepsy. Epilepsia 41 (2000) 1227-1229